Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patients.
Chiara PellicanoAmalia ColalilloOriana De MarcoValeria CarnazzoUmberto BasileAntonietta GiganteRosario CianciEdoardo RosatoPublished in: Clinical and experimental medicine (2024)
SSc patients had higher FGF-23, Klotho and NGAL than HC. Iloprost reduces serum levels of FGF-23, Klotho and NGAL.